Literature for peptidase M28.012: glutamate carboxypeptidase III

Summary Gene structure Alignment Tree Sequences Sequence features Distribution Structure Literature Substrates Pharma

(Topics flags: S Structure, P Specificity, I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)

2023

Lee,Z., Heston,W.D., Wang,X. and Basilion,J.P. GCP III is not the "off-target" for urea-based PSMA ligands Eur J Nucl Med Mol Imaging (2023) 50, 2944-2946. PubMed Europe PubMed DOI PMC EPMC
Lucaroni,L., Georgiev,T., Prodi,E., Puglioli,S., Pellegrino,C., Favalli,N., Prati,L., Manz,M.G., Cazzamalli,S., Neri,D., Oehler,S. and Bassi,G. Cross-reactivity to glutamate carboxypeptidase III causes undesired salivary gland and kidney uptake of PSMA-targeted small-molecule radionuclide therapeutics Eur J Nucl Med Mol Imaging (2023) 50, 957-961. PubMed Europe PubMed DOI

2020

Arteaga Cabeza,O., Zhang,Z., Smith Khoury,E., Sheldon,R.A., Sharma,A., Zhang,F., Slusher,B.S., Kannan,R.M., Kannan,S. and Ferriero,D.M. Neuroprotective effects of a dendrimer-based glutamate carboxypeptidase inhibitor on superoxide dismutase transgenic mice after neonatal hypoxic-ischemic brain injury Neurobiol Dis (2020) 148, 105201-105201. PubMed Europe PubMed DOI I

2016

Navratil,M., Tykvart,J., Schimer,J., Pachl,P., Navratil,V., Rokob,T.A., Hlouchova,K., Rulisek,L. and Konvalinka,J. Comparison of human glutamate carboxypeptidases II and III reveals their divergent substrate specificities FEBS J (2016) 283, 2528-2545. PubMed Europe PubMed DOI

2012

Hlouchova,K., Navratil,V., Tykvart,J., Sacha,P. and Konvalinka,J. GCPII variants, paralogs and orthologs Curr Med Chem (2012) 19, 1316-1322. PubMed Europe PubMed DOI

2011

Collard,F., Vertommen,D., Constantinescu,S., Buts,L. and Van Schaftingen,E. Molecular identification of beta-citrylglutamate hydrolase as glutamate carboxypeptidase 3 J Biol Chem (2011) 286, 38220-38230. PubMed Europe PubMed DOI

2009

Hlouchova,K., Barinka,C., Konvalinka,J. and Lubkowski,J. Structural insight into the evolutionary and pharmacologic homology of glutamate carboxypeptidases II and III FEBS J (2009) 276, 4448-4462. PubMed Europe PubMed DOI S

2007

Hlouchova,K., Barinka,C., Klusak,V., Sacha,P., Mlcochova,P., Majer,P., Rulisek,L. and Konvalinka,J. Biochemical characterization of human glutamate carboxypeptidase III J Neurochem (2007) 101, 682-696. PubMed Europe PubMed DOI P

2004

Bzdega,T., Crowe,S.L., Ramadan,E.R., Sciarretta,K.H., Olszewski,R.T., Ojeifo,O.A., Rafalski,V.A., Wroblewska,B. and Neale,J.H. The cloning and characterization of a second brain enzyme with NAAG peptidase activity J Neurochem (2004) 89, 627-635. PubMed Europe PubMed DOI I
Olszewski,R.T., Bukhari,N., Zhou,J., Kozikowski,A.P., Wroblewski,J.T., Shamimi-Noori,S., Wroblewska,B., Bzdega,T., Vicini,S., Barton,F.B. and Neale,J.H. NAAG peptidase inhibition reduces locomotor activity and some stereotypes in the PCP model of schizophrenia via group II mGluR J Neurochem (2004) 89, 876-885. PubMed Europe PubMed DOI I

1999

[YEAR:26-3-1999]Pangalos,M.N., Neefs,J.M., Somers,M., Verhasselt,P., Bekkers,M., van der Helm,L., Fraiponts,E., Ashton,D. and Gordon,R.D. Isolation and expression of novel human glutamate carboxypeptidases with N-acetylated alpha-linked acidic dipeptidase and dipeptidyl peptidase IV activity J Biol Chem (26-3-1999) 274, 8470-8483. PubMed Europe PubMed DOI